- Home
- GOCO vs GNTA Comparison
GOCO vs GNTA Comparison
Compare GOCO & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOCO | GNTA |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 13 |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 19.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | GOCO | GNTA |
|---|---|---|
| Price | $1.69 | $0.62 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 75.5K | 60.1K |
| Earning Date | 05-12-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $798,894,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.74 | N/A |
| 52 Week Low | $1.31 | $0.59 |
| 52 Week High | $13.47 | $10.00 |
Technical Indicators
Market Signals| Indicator | GOCO | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 39.48 |
| Support Level | N/A | $0.71 |
| Resistance Level | $2.53 | $1.70 |
| Average True Range (ATR) | 0.19 | 0.08 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 35.82 | 42.51 |
Price Performance
Historical ComparisonAbout GOCO GoHealth Inc.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.